MedPath

A Comparison Study of the Perclose Proglide (TM) SMC System Versus Figure-of-8- Suture Technique for Closure of Large-bore Femoral Venous Access.

Recruiting
Conditions
Cardiovascular Diseases
Interventions
Other: Closure Strategy with Perclose-Proglide system
Other: Closure Strategy with figure-of-8
Registration Number
NCT05859503
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Brief Summary

This study aims to compare the efficacy and safety of two strategies for closing large caliber venous access in patients undergoing percutaneous procedures: compression with figure-of-8 suture versus closure with the Perclose-Proglide system.

Detailed Description

This is a retrospective observational study that aims to compare two strategies for closing large-caliber femoral venous access in patients who have undergone percutaneous procedures.

The study's goal is to determine if there are significant differences in terms of efficacy and safety between the two closure strategies. Figure-of-8 suture compression is a well-established technique that has been used for decades to close large-bore femoral venous access, while the Perclose-Proglide system is a relatively new medical device that could have great utility for the closure of large-bore femoral venous access. By comparing these two strategies, researchers hope to determine the safety and effectiveness of the Perclose-Proglide system for closing large-bore femoral venous access in patients undergoing percutaneous procedures.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria

Patients will meet all inclusion criteria:

  • Adult patients aged > 18 years
  • Patients who have undergone percutaneous interventional procedures
  • Patients in whom the procedures have been performed with femoral venous access
  • Patients who have required large caliber pods ≥ 14 French.
Exclusion Criteria

Patients must not meet any exclusion criteria:

  • Patients who have required access with surgical exposure.
  • Patients who have required ipsilateral arterial access with a large caliber ≥ 14 French
  • Patients with previous vascular surgery.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Perclose-Proglide systemClosure Strategy with Perclose-Proglide system-
Figure-of-8Closure Strategy with figure-of-8-
Primary Outcome Measures
NameTimeMethod
Assessment of rebleedingDischarge (assessed up to day 5)

Incidence of patients with rebleeding

Rebleeding30 days

Incidence of patients with rebleeding

Assessment of Major vascular complicationsDischarge (assessed up to day 5)

Incidence of patients with Major vascular complications

Secondary Outcome Measures
NameTimeMethod
Assessment of Hematoma Size24 hours

Area in cm of the hematoma at the venous puncture in patients with hematoma

Assessment of Hematoma24 hours

Incidence of patients with hematoma the venous puncture

Assessment of sitting-walking timeDischarge (assessed up to day 5)

Time in hours between the patient sitting and walking after the vascular access

Assessment of Technical success1 minute after closure performed

Technical success when complete hemostasis is less than 1 minute after closure strategy performed

Assessment of Urinary infectionsDischarge (assessed up to day 5)

Incidence of patients with urinary infection

Assessment of Clinical successDischarge (assessed up to day 5)

Technical success in the absence of events after closure strategy

Assessment of Death30 days

Incidence of dead patients

Assessment of Death related to vascular accessDischarge (assessed up to day 5)

Incidence of dead patients related to vascular access

Assessment of Vascular access point infection30 days

Incidence of patients with infection in vascular access point

Trial Locations

Locations (1)

Hospital Universitari Vall D'Hebron

🇪🇸

Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath